首页> 美国卫生研究院文献>Elsevier Sponsored Documents >Striatal dopamine D2/D3 receptor binding in pathological gambling is correlated with mood-related impulsivity
【2h】

Striatal dopamine D2/D3 receptor binding in pathological gambling is correlated with mood-related impulsivity

机译:病理性赌博中纹状体多巴胺D2 / D3受体结合与情绪相关冲动相关

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Pathological gambling (PG) is a behavioural addiction associated with elevated impulsivity and suspected dopamine dysregulation. Reduced striatal dopamine D2/D3 receptor availability has been reported in drug addiction, and may constitute a premorbid vulnerability marker for addictive disorders. The aim of the present study was to assess striatal dopamine D2/D3 receptor availability in PG, and its association with trait impulsivity. Males with PG (n = 9) and male healthy controls (n = 9) underwent [11C]-raclopride positron emission tomography imaging and completed the UPPS-P impulsivity scale. There was no significant difference between groups in striatal dopamine D2/D3 receptor availability, in contrast to previous reports in drug addiction. However, mood-related impulsivity (‘Urgency’) was negatively correlated with [11C]-raclopride binding potentials in the PG group. The absence of a group difference in striatal dopamine binding implies a distinction between behavioural addictions and drug addictions. Nevertheless, our data indicate heterogeneity in dopamine receptor availability in disordered gambling, such that individuals with high mood-related impulsivity may show differential benefits from dopamine-based medications.
机译:病理性赌博(PG)是一种行为上瘾,与冲动性增强和怀疑的多巴胺失调有关。药物成瘾中已报告纹状体多巴胺D2 / D3受体的可用性降低,并且可能构成成瘾性疾病的病前易损性标记。本研究的目的是评估PG中纹状体多巴胺D2 / D3受体的有效性及其与性冲动的关系。 PG(n = 9)和男性健康对照组(n = 9)的男性接受了[11C]-雷氯必利正电子发射断层显像,并完成了UPPS-P冲动量表。与以前关于药物成瘾的报道相反,纹状体多巴胺D2 / D3受体的可用性在两组之间没有显着差异。但是,与情绪相关的冲动(“紧急”)与PG组中的[11C]-雷氯必利结合潜力呈负相关。纹状体多巴胺结合中没有群体差异意味着行为成瘾和药物成瘾之间有区别。但是,我们的数据表明,在无序赌博中多巴胺受体的可用性存在异质性,因此情绪相关冲动性高的人可能会从基于多巴胺的药物中获得不同的收益。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号